Home
Emmessar Biotech & Nutrition Ltd Share Price History
Emmessar Biotech & Nutrition Ltd
BSE : 21 Feb, 2025
33.730.7 (2.2%)
Prev Close
33.0
Open Price
36.3
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
4082
Today's High / Low
36.3 / 30.5
52 WK High / Low
64.0 / 27.9
Market Price of Emmessar Biotech & Nutrition Ltd
1M
1Y
3Y
5Y
Monitoring Emmessar Biotech & Nutrition Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2017 |
|---|---|
| Sales (Cr.) | 3 |
| Sales YoY Gr. | - |
| Adj EPS | 2.38 |
| YoY Gr. | - |
| Net Profit (Cr.) | 1 |
| BVPS | 4.18 |
Key Financial Parameters
| Parameter | 2017 |
|---|---|
| Return on Capital Emp. % | 33.15 |
| Op. Profit Mgn % | 44.81 |
| Net Profit Mgn % | 44.07 |
| Debt to Equity % | 0 |
Latest Shareholding
Promoters Holdings Over Time
About Emmessar Biotech & Nutrition Ltd
- Emmessar Biotech & Nutrition Limited, originally established on 17th March 1992 as Emmessar Chemical Industries Ltd (ECIL) started its operations in manufacturing Super Specialty Fine Chemicals.
- The Company has so far, succeeded in developing many Specialty Fine Chemicals.
- ECIL gained official recognition for its R&D from DSIR, Ministry of Science & Technology, Government of India, New-Delhi in early 1996.
- To better represent its new core activity, a change in the Company name from Emmessar Chemical Industries Ltd (ECIL) to Emmessar Biotech & Nutrition Ltd (EBNL) on April 7, 2000, was made essential. On realizing that some of the specialty chemicals developed & exported to USA & Europe was being used in producing healthcare formulations, the Company plunged into a new venture in the Healthcare business, where phenomenal growth in the coming decades was anticipated.
Popular Search
FAQs for Emmessar Biotech & Nutrition Ltd Share Price History
What are the key events that typically impact Emmessar Biotech & Nutrition Ltd's share price history?
Key events that impact Emmessar Biotech & Nutrition Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Emmessar Biotech & Nutrition Ltd's share price history?
Stock splits reduce the nominal price of Emmessar Biotech & Nutrition Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Emmessar Biotech & Nutrition Ltd?
Dividends can influence Emmessar Biotech & Nutrition Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Emmessar Biotech & Nutrition Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Emmessar Biotech & Nutrition Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Emmessar Biotech & Nutrition Ltd’s share price history?
To understand Emmessar Biotech & Nutrition Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
